RVL Pharmaceuticals PLC (RVLPQ)

0.0033 -0.0002 (-5.71%)
Closed USD Disclaimer
0.0033 0.0000 (0.0000%)

RVL Pharmaceuticals PLC Company Profile

Equity Type
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Contact Information
Bridgewater,08807 United States
908 809 1300
908 809 1301
Top Executives
Fred G. Weiss 79 2018 Non-Executive Independent Director
Brian A. Markison 63 2016 Chairman, President, CEO & Principal Financial Officer
Gregory L. Cowan 69 2019 Independent Director
Michael J. DeBiasi 47 2019 Independent Director
Alisa Lask 52 2022 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.